RORα regulates myriad metabolic pathways and based on the phenotype of the staggerer mice as well as the RORα null mice, RORα is a potential target to treat diseases such as atherosclerosis, diabetes, and osteoporosis as well as disorders associated with disruption of the circadian rhythm. This evidence concerns the gene RORA and osteoporosis.